Atlas Trials

The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)

Clinical trial NCT06867588 · RECRUITING

Trial details

NCT number
NCT06867588
Sponsor
Jules Bordet Institute
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiparametric MRILesion PI-RADS 3
Start date
2024-10-17
Primary completion
2026-10-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.